BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 35549914)

  • 1. Level IV neck dissection in cN0 HPV-negative oropharyngeal squamous cell carcinoma: a retrospective cohort study.
    Huo Z; Fu S; Ma C; Sheng S
    BMC Cancer; 2022 May; 22(1):535. PubMed ID: 35549914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncologic outcomes of selective neck dissection in HPV-related oropharyngeal squamous cell carcinoma.
    Zenga J; Jackson RS; Graboyes EM; Sinha P; Lindberg M; Martin EJ; Ma D; Thorstad WL; Rich JT; Moore EJ; Haughey BH
    Laryngoscope; 2017 Mar; 127(3):623-630. PubMed ID: 27634021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome after elective neck dissection and observation for the treatment of the clinically node-negative neck (cN0) in squamous cell carcinoma of the oropharynx.
    Böscke R; Cakir BD; Hoffmann AS; Wiegand S; Quetz J; Meyer JE
    Eur Arch Otorhinolaryngol; 2014 Mar; 271(3):567-74. PubMed ID: 23661061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disparities in survival outcomes among Black patients with HPV-associated oropharyngeal cancer.
    Baliga S; Mitchell D; Yildiz VO; Gogineni E; Konieczkowski DJ; Grecula J; Blakaj DM; Liu X; Gamez ME
    J Med Virol; 2023 Feb; 95(2):e28448. PubMed ID: 36583477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic effect of radiological extranodal extension in HPV-positive oropharyngeal squamous cell carcinomas: a retrospective cohort analysis.
    Meulemans J; Werpin L; Hermans R; Laenen A; Nuyts S; Clement PM; Delaere P; Van Lierde C; Vander Poorten V
    Eur Arch Otorhinolaryngol; 2024 Mar; 281(3):1541-1558. PubMed ID: 38170212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of immune makers with HPV 16 infections and the prognosis in oropharyngeal squamous cell carcinoma.
    Zhu Y; Zhu X; Diao W; Liang Z; Gao Z; Chen X
    Clin Oral Investig; 2023 Apr; 27(4):1423-1433. PubMed ID: 36884083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Females Have Worse Overall and Disease-Specific Survival in Human Papillomavirus-Negative Oropharyngeal Squamous Cell Carcinoma.
    Hunter WP; Harris JA; Lee CC; Cheng AC; Peacock ZS
    J Oral Maxillofac Surg; 2022 Jul; 80(7):1260-1271. PubMed ID: 35469827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison between p16-positive head and neck cancer of unknown primary (HPV-HNCUP) and oropharyngeal squamous cell carcinoma (HPV-OPSCC): are they the same disease?
    Balk M; Rupp R; Sievert M; Mantsopoulos K; Allner M; Grundtner P; Mueller SK; Eckstein M; Iro H; Hecht M; Gostian AO
    Eur Arch Otorhinolaryngol; 2023 Dec; 280(12):5489-5497. PubMed ID: 37505261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of cervical node positivity, regional failure rates, and fistula rates for HPV+ oropharyngeal squamous cell carcinoma treated with transoral robotic surgery (TORS).
    Cannon RB; Houlton JJ; Patel S; Raju S; Noble A; Futran ND; Parvathaneni U; Méndez E
    Oral Oncol; 2018 Nov; 86():296-300. PubMed ID: 30409315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of extranodal extension (ENE) in surgically managed treatment-naive HPV-positive oropharyngeal squamous cell carcinoma with nodal metastasis.
    Xu B; Saliba M; Alzumaili B; Alghamdi M; Lee N; Riaz N; Patel SG; Ganly I; Dogan S; Ghossein RA; Katabi N
    Mod Pathol; 2022 Nov; 35(11):1578-1586. PubMed ID: 35690646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
    Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
    Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns and distribution of regional nodal involvement and recurrence in a surgically treated oropharyngeal squamous cell carcinoma cohort at a tertiary center.
    Abdel-Halim CN; O'Byrne TJ; Graves JP; Akpala CO; Moore EJ; Price DL; Tasche KT; Ma DJ; Neben-Wittich MA; Lester SC; Gamez M; Price KA; Bayne HEF; Rwigema JCM; Patel SH; McGee LA; Janus JR; Nagel TH; Hinni ML; Savvides PS; Van Abel KM; Routman DM
    Oral Oncol; 2023 Nov; 146():106569. PubMed ID: 37734203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of surgically treated human papillomavirus-related oropharyngeal squamous cell carcinoma with N3 disease.
    Zenga J; Haughey BH; Jackson RS; Adkins DR; Aranake-Chrisinger J; Bhatt N; Gay HA; Kallogjeri D; Martin EJ; Moore EJ; Paniello RC; Rich JT; Thorstad WL; Nussenbaum B
    Laryngoscope; 2017 Sep; 127(9):2033-2037. PubMed ID: 28008626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the Seventh and Eighth Edition of American Joint Committee on Cancer (AJCC) Staging for Selected and Nonselected Oropharyngeal Squamous Cell Carcinomas.
    Vijayvargiya P; Trivedi S; Rupji M; Song H; Liu Y; Jiang R; Kaka AS; Chen GZ; Stokes W; Steuer C; Shin DM; Beitler JJ; Patel MR; Aiken A; Saba NF
    Oncologist; 2022 Feb; 27(1):48-56. PubMed ID: 35305095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of the lymph node ratio in oropharyngeal carcinoma stratified for HPV-status.
    Jacobi C; Rauch J; Hagemann J; Lautz T; Reiter M; Baumeister P
    Eur Arch Otorhinolaryngol; 2018 Feb; 275(2):515-524. PubMed ID: 29204919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Survival of Patients With T
    Zeng X; Peng L; Wen W; Sun W
    Laryngoscope; 2022 Jun; 132(6):1205-1212. PubMed ID: 34797566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of human papillomavirus status on prognosis and local treatment strategies of T1-2N0 oropharyngeal squamous cell cancer.
    Zhou P; Chen DL; Lian CL; Wu SG; Zhang SY
    Front Public Health; 2022; 10():900294. PubMed ID: 35958856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional Genetic Variants in TGFβ1 and TGFβR1 in miRNA-Binding Sites Predict Outcomes in Patients with HPV-positive Oropharyngeal Squamous Cell Carcinoma.
    Niu Z; Sun P; Liu H; Wei P; Wu J; Huang Z; Gross ND; Shete S; Wei Q; Zafereo ME; Calin GA; Li G
    Clin Cancer Res; 2023 Aug; 29(16):3081-3091. PubMed ID: 37327315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of human papillomavirus detection and the eighth edition of the TNM classification staging system in oropharyngeal squamous cell carcinoma: A single-center Polish study.
    Durzynska M; Kiprian D; Szumera-Cieckiewicz A; Leszczynski P; Florek A; Snietura M; Michalek IM; Bakula-Zalewska E; Prochorec-Sobieszek M
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Jun; 133(6):698-705. PubMed ID: 35165063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rate of atypical nodal metastases in surgically treated HPV-associated oropharyngeal squamous cell carcinoma.
    Miller LE; Au VH; Sivarajah S; Lin DT; Deschler DG; Varvares MA; Faden DL; Feng AL; Sadow PM; Richmon JD
    Head Neck; 2023 Feb; 45(2):409-416. PubMed ID: 36416254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.